BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time
BioHarvest Sciences (NASDAQ: BHST) will release third quarter 2025 financial results for the period ended September 30, 2025 after market close on Thursday, November 13, 2025. Management will host an investor conference call and webcast at 4:30 p.m. Eastern time on November 13 to discuss Q3 2025 results, provide a corporate update, and hold a Q&A session for telephone participants.
Call details: U.S./Canada dial-in 1-877-300-8521; international dial-in 1-412-317-6026; conference ID 6486821. A telephone playback will be available through Thursday, November 27, 2025 (U.S./Canada replay 1-844-512-2921; international 1-412-317-6671; replay PIN 10204225). A webcast and replay will be available via the company webcast link.
BioHarvest Sciences (NASDAQ: BHST) annuncerà i risultati finanziari del terzo trimestre 2025 per il periodo terminato 30 settembre 2025 dopo la chiusura del mercato di giovedì 13 novembre 2025. Il management terrà una conference call per investitori e una webcast alle 16:30 ora orientale del 13 novembre per discutere i risultati del Q3 2025, fornire un aggiornamento aziendale e condurre una sessione di domande e risposte per i partecipanti telefonici.
Dettagli della chiamata: numero USA/Canada 1-877-300-8521; numero internazionale 1-412-317-6026; ID conferenza 6486821. Una riproduzione telefonica sarà disponibile fino a giovedì 27 novembre 2025 (riproduzione USA/Canada 1-844-512-2921; internazionale 1-412-317-6671; PIN di riproduzione 10204225). Una webcast e la riproduzione saranno disponibili tramite il link della webcast dell'azienda.
BioHarvest Sciences (NASDAQ: BHST) publicará los resultados financieros del tercer trimestre de 2025 para el periodo terminado al 30 de septiembre de 2025 después del cierre de mercado el jueves 13 de noviembre de 2025. La dirección organizará una conferencia para inversionistas y una transmisión web a las 4:30 p.m. hora del Este el 13 de noviembre para discutir los resultados del 3T 2025, proporcionar una actualización corporativa y realizar una sesión de preguntas y respuestas para los participantes por teléfono.
Detalles de la llamada: marcación para Estados Unidos/Canadá 1-877-300-8521; marcación internacional 1-412-317-6026; ID de la conferencia 6486821. Una reproducción telefónica estará disponible hasta el jueves 27 de noviembre de 2025 (revisión EE. UU./Canadá 1-844-512-2921; internacional 1-412-317-6671; código de reproducción 10204225). Una transmisión y reproducción estarán disponibles a través del enlace de transmisión de la compañía.
BioHarvest Sciences (NASDAQ: BHST)는 2025년 9월 30일에 종료된 기간의 2025년 3분기 재무실적을 2025년 11월 13일 목요일 장 마감 후 발표합니다. 경영진은 11월 13일 동부 표준시 기준 오후 4시 30분에 투자자 컨퍼런스 콜 및 웹캐스트를 개최하여 2025년 3분기 결과를 논의하고, 기업 업데이트를 제공하며 전화 참가자를 위한 Q&A 시간을 가질 예정입니다.
통화 정보: 미국/캐나다 다이얼링 1-877-300-8521; 국제 다이얼링 1-412-317-6026; 컨퍼런스 ID 6486821. 전화 재생은 2025년 11월 27일 목요일까지 제공됩니다(미국/캐나다 재생 1-844-512-2921; 국제 1-412-317-6671; 재생 PIN 10204225). 웹캐스트 및 재생은 회사의 웹캐스트 링크를 통해 이용 가능합니다.
BioHarvest Sciences (NASDAQ: BHST) publiera les résultats financiers du troisième trimestre 2025 pour la période se terminant le 30 septembre 2025 après la clôture du marché le jeudi 13 novembre 2025. La direction organisera une conférence téléphonique pour investisseurs et une webdiffusion à 18h30, heure de l'Est le 13 novembre pour discuter des résultats du T3 2025, fournir une mise à jour de l'entreprise et tenir une séance de questions/réponses pour les participants téléphoniques.
Détails de l'appel : numérotation États‑Unis/Canada 1-877-300-8521; numérotation internationale 1-412-317-6026; identifiant de la conférence 6486821. Une publication téléphonique sera disponible jusqu’au jeudi 27 novembre 2025 (relecture États‑Unis/Canada 1-844-512-2921; internationale 1-412-317-6671; code de reproduction 10204225). Une webdiffusion et une rediffusion seront disponibles via le lien de webdiffusion de l’entreprise.
BioHarvest Sciences (NASDAQ: BHST) wird die Finanzergebnisse des dritten Quartals 2025 für den Zeitraum bis zum 30. September 2025 nach Börsenschluss am Donnerstag, 13. November 2025 veröffentlichen. Das Management wird am 13. November um 16:30 Uhr Eastern Time eine Investorenkonferenz und einen Webcast abhalten, um die Ergebnisse des Q3 2025 zu diskutieren, ein Unternehmensupdate zu geben und eine Q&A-Sitzung für telefonische Teilnehmer abzuhalten.
Details zur Anrufung: US/Kanada Durchwahl 1-877-300-8521; internationale Durchwahl 1-412-317-6026; Konferenz-ID 6486821. Eine telefonische Wiedergabe ist bis zum Donnerstag, 27. November 2025 verfügbar (US/Canada Wiedergabe 1-844-512-2921; international 1-412-317-6671; Wiedergabe-PIN 10204225). Ein Webcast und eine Wiedergabe sind über den Unternehmens-Webcast-Link verfügbar.
BioHarvest Sciences (NASDAQ: BHST) ستصدر نتائج الربع الثالث من عام 2025 للفترة المنتهية في 30 سبتمبر 2025 بعد إغلاق السوق يوم الخميس 13 نوفمبر 2025. ستستضيف الإدارة مكالمة مؤتمرات للمستثمرين وبثًا حيًا عبر الويب في الساعة 4:30 مساءً بتوقيت الساحل الشرقي في 13 نوفمبر لمناقشة نتائج الربع الثالث 2025، وتقديم تحديث مؤسسي، وعقد جلسة أسئلة وأجوبة للمشاركين عبر الهاتف.
تفاصيل الاتصال: الدخول من الولايات المتحدة/كندا 1-877-300-8521; الدخول الدولي 1-412-317-6026; معرف المؤتمر 6486821. سيكون هناك تشغيل صوتي عبر الهاتف حتى الخميس 27 نوفمبر 2025 (إعادة الولايات المتحدة/كندا 1-844-512-2921؛ الدولي 1-412-317-6671؛ رقم إعادة التشغيل 10204225). وستتوفر بث ويب وإعادة تشغيل عبر رابط بث الشركة.
- None.
- None.
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the third quarter ended September 30, 2025 after market close on Thursday, November 13, 2025.
Management will host an investor conference call and webcast at 4:30 p.m. Eastern time on Thursday, November 13, 2025 to discuss the Company's third quarter 2025 financial results, provide a corporate update, and conclude with a question-and-answer session from telephone participants. To participate, please use the following information:
Third Quarter 2025 Earnings Conference Call
Date: Thursday, November 13, 2025
Time: 4:30 p.m. Eastern time
U.S./Canada Dial-in: 1-877-300-8521
International Dial-in: 1-412-317-6026
Conference ID: 6486821
Webcast: BHST Q3 2025 Earnings Conference Call
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
A telephone playback of the call will be available through Thursday, November 27, 2025. To listen, call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 10204225. A webcast replay will also be available at the webcast link above.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHST@mzgroup.us

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273107